Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v8-EN
Language English English
Date Updated 2020-10-29 2020-10-29
Drug Identification Number 01924559 01924559
Brand name DEXEDRINE SPANSULE SRC 10MG DEXEDRINE SPANSULE SRC 10MG
Common or Proper name DEXTROAMPHETAMINE SULFATE DEXTROAMPHETAMINE SULFATE
Company Name PALADIN LABS INC. PALADIN LABS INC.
Ingredients DEXTROAMPHETAMINE SULFATE DEXTROAMPHETAMINE SULFATE
Strength(s) 10MG 10MG
Dosage form(s) CAPSULE (SUSTAINED-RELEASE) CAPSULE (SUSTAINED-RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 caps 100 caps
ATC code N06BA N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2020-08-27 2020-08-27
Actual start date
Estimated end date 2020-11-01 2020-11-01
Actual end date 2020-10-28 2020-10-28
Shortage status Resolved Resolved
Company comments
Health Canada comments